Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05445804 · ClinicalTrials.gov registry record · Phase 1
Oral Cannabidiol for Tobacco Cessation
A Phase 1 study of Tobacco Use and Tobacco Use Disorder, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT05445804 is a Phase 1 study of Tobacco Use and Tobacco Use Disorder that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 50 participants, below the 378-participant average among 76 other Tobacco Use trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05445804, a Phase 1 study of Tobacco Use and Tobacco Use Disorder, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Cannabidiol is a compound found in cannabis plants that is well tolerated, has low abuse liability, and might be an effective medication to promote tobacco cessation. This clinical study will use a validated approach for screening tobacco cessation medications to determine if oral cannabidiol increases short-term tobacco abstinence, and evaluate mechanisms that might explain how cannabidiol alters smoking behavior. Results from this study will provide data on the therapeutic potential of cannabidiol for tobacco cessation.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG 300 mg Cannabidiol
- DRUG 600 mg Cannabidiol
Study Locations (1)
Maryland
- Johns Hopkins Behavioral Pharmacology Research Unit - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-11-01 |
| Est. Completion | 2027-02-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05445804
The ClinicalTrials.gov registry entry for NCT05445804 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 378-participant average among 76 other Tobacco Use trials with a reported enrollment target (87% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Tobacco Use appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT05445804 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT05445804 about?
NCT05445804 is a clinical study titled "Oral Cannabidiol for Tobacco Cessation". Cannabidiol is a compound found in cannabis plants that is well tolerated, has low abuse liability, and might be an effective medication to promote tobacco cessation. This clinical study will use a validated approach for screening tobacco cessation medications to determine if oral cannabidiol increa...
What is the current status of trial NCT05445804?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2022-11-01. Estimated completion is 2027-02-01.
What conditions does trial NCT05445804 study?
This clinical trial studies the following conditions: Tobacco Use, Tobacco Use Disorder, Tobacco Smoking, Tobacco Use Cessation, Tobacco Dependence.
What interventions are being tested in trial NCT05445804?
The interventions under investigation include: Placebo (DRUG), 300 mg Cannabidiol (DRUG), 600 mg Cannabidiol (DRUG).
Who is sponsoring clinical trial NCT05445804?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05445804 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Cannabis on Cigarette Use Behavior
RECRUITING · Phase 1
-
Overcoming Nicotine Dependence to Enable Quitting
RECRUITING · Phase 1
-
Effect of Cannabis on E-Cigarette Use Behavior
RECRUITING · Phase 1
-
Emergency Department Initiated Tobacco Treatment (EDITT)
COMPLETED · Phase 1
-
Evaluation of the Abuse Liability of Very Low Nicotine (VLN) Cigarettes
COMPLETED · Phase 1
-
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.